Hopewell Pharma Ventures, Inc. et al. v. Merck Serono SA > Summary
Court Case Number IPR2023-00480
Filing Date Jan 23, 2023
Court Patent Trial and Appeal Board
Status Trial Instituted
Claims Challenged in the Petition: 36, 38, 39, 41, 42, 43, 44, 45, 46
Petitioner
Patent Owner
Petitioner Attorneys
8Hopewell Pharma Ventures
Attorney Name: Olga A. Partington
Sterne, Kessler, Goldstein & Fox
Hopewell Pharma Ventures
Attorney Name: Chandrika Vira
Sterne, Kessler, Goldstein & Fox
Attorney Name: John Christopher Rozendaal
Sterne, Kessler, Goldstein & Fox
Attorney Name: Vinita Ferrera
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: Christina Elizabeth Dashe
STERNE, KESSLER, GOLDSTEIN & FOX PLLC
Attorney Name: David Mlaver
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: Mary Pheng
Wilmer Cutler Pickering Hale and Dorr
Patent Owner Attorneys
7MERCK SERONO SA
Attorney Name: Deric X. Geng
Wilmer Cutler Pickering Hale and Dorr
MERCK SERONO SA
Attorney Name: Emily R. Whelan
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: David B. Bassett
Wilmer Cutler Pickering Hale and Dorr
MERCK SERONO SA
Wilmer Cutler Pickering Hale and Dorr
MERCK SERONO SA
Wilmer Cutler Pickering Hale and Dorr
Attorney Name: Asher S. McGuffin
Wilmer Cutler Pickering Hale and Dorr
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07713947 | Cladribine regimen for treating multiple sclerosis | May 11, 2010 |
